Note: The CDC published a revised view of lead in 2012, so material on this page may be outdated. See the glossary entry for more information.
The inorganic compounds which are of concern in ceramics are :
This product is unstable under the following conditions : when heated it decomposes at 400 degrees Celsius and emits lead monoxide, carbon monoxide and carbon dioxide.
In the relevant literature, we have not found any information relating to thermal breakdown products for the following lead frits: lead bisilicate, lead sesquisilicate and lead-boro-silicate.
On the other hand lead silicate, PbO.SiO2, emits toxic lead fumes when heated to decomposition.
This product is unstable under the following conditions : when heated to decomposition (more than 500 degrees Celsius), there is release of oxygene and emission of toxic lead fumes.
This product is unstable under the following conditions : when heated between 300 to 400 degrees Celsius, it is converted to lead tetroxide.
Lead is not metabolized in the body.
E- Excretion :Lead toxicokinetics and toxicological effects can be affected by interactions with certain essential elements and nutriments
Acute intoxication is rare in the work environment. The inhalation of significant lead amounts can cause digestive disorders (vomiting, epigastric and abdominal pain, diarrhoea and black stools), renal disorders, hemolytic anemia, neurological disorders (encephalopathy, intracranial hypertension, convulsive coma).
A. The effects of lead intoxication in man are the same whatever the route of entry into the body. They are generally described in terms of internal dose (amounts of lead in the blood ) rather than in terms of ambient level of exposure (mg/m³ or ppm).
B. One of the first symptoms of lead exposure is the appearance of digestive disorders.
This results in colics (intense abdominal pains, nausea, vomiting), constipation, anorexia and a loss of weight.
C. Articular and muscular pains in the extremities are also reported.
D. A blue coloured line has been observed on the gingival tissues of people exposed to significant lead concentrations.
E. Lead exerts certain blood effects. It induces anemia (caused by a reduction in the lifespan of red cells and by a fall of the synthesis of heme by enzymatic inhibition). It also involves an increased production of abnormal erythrocytes.
F. Lead has effects on the nervous system thus being able to cause encephalopathy and peripheral neuropathy.
The first symptoms of encephalopathy can appear in the weeks following initial exposure to lead; these are irritability, lassitude, loss of appetite, reduction in the attention,headaches, jerked movements of the eyes, hallucinations, a deterioration of the cognitive functions (reduction in the performance in certain psychometric tests like, for example, eye-hand coordination, skills of verbal reasoning, memory, etc).
Symptoms may worsen, sometimes abruptly, and one can observe delirium, convulsions, paralysis, coma and death. Peripheral neuropathy can result in muscular tremors, weakness of the upper limbs and paraesthesias of the lower limbs (pins and needles, tingling).
G. Workers exposed to lead present an increased risk of chronic nephrotoxicity.
The lead levels which can cause such an effect seem to be a function of the duration of exposure. A review of several studies seems to indicate that lead can cause nephropathy at blood lead levels as low as 1,93 µmol/l.
Certain toxic effects are reversible whereas others are not. A recent study suggests that the exposure to low lead levels can cause renal problems in middle-age and old age men.
H. Some studies suggest that there is a weak positive correlation between blood lead level (BLL) and an increase in blood pressure. However, it is currently premature to draw conclusions on this subject.
I. There is some evidence that high lead doses could be responsible for cardiac lesions and disturbances in the electrocardiogram.
J. According to some studies, lead could weaken the immune system.
Variable according to different organizations, (time of blood sampling is discretionary); the ACGIH proposes 1,45 µmol/L (level aiming at minimizing or preventing the effects being able to result in a persistent functional damage); the WHO and Lauwerys propose 1,93 µmol/L (maximum tolerable blood lead level); the level in non-exposed individuals is < 0,50 µmol/L.
B-Zinc protoporphyrins (ZPP):The time of blood sampling must be at least one month after the beginning of exposure. Lauwerys proposes 0,67 µmol/L in order to prevent certain health effects. The level for non-exposed individuals is < 0,32 µmol/L.
Urinary aminolevulinic acid : an indicator of toxic effect; this test is less sensitive than the measurement of ZPP.
A-BLL :
B-ZPP :
| Blood lead level (µmol/l) |
Effect |
| < 0,48 | Blood lead level of a nonexposed person |
| 0,97 à 2,90 | Increase in the concentration of erythrocyte protoporphyrins |
| > 1,93 | Increase in the urinary concentration of coproporphyrin |
| 2,41 à 2,90 | Chronic encephalopathy in the child |
| > 3,86 | Chronic encephalopathy in the adult |
| 2,90 à 3,86 | Peripheral neuropathy |
| 3,38 à 4,80 | Nephropathies |
| 3,86 à 4,80 | Anemia |
| 3,86 à 14,5 | Acute encephalopathy |
µg/l x 0,004826 = µmol/l
A- People suffering from a neurological dysfonction;
B- People suffering from a renal disease;
C- People having certain genetic diseases, such as thalassemia, glucose-6 phosphate dehydrogenase deficiency, porphyrias, an excessive activity of the ALA synthase.
D- Children;
E- Pregnant or breast-feeding women;
F- The embryo or foetus;
G- Elderlies;
H- Smokers;
I- Alcoholics.
ACGIH evaluation : Confirmed animal carcinogen (group A3).
IARC.evaluation: Probably carcinogenic to humans (group 2B).
ACGIH evaluation: Confirmed animal carcinogen (group A3).
A- Basic Lead Carbonate
B- Red Lead Oxide
C- Yellow Lead Oxide
Exposure limit in Quebec :
Note
Comments
Main measures are as follows:
A. Work organization
B. Ventilation
C. General cleanliness of workstations
D. Sanitary equipment
E. Regular evaluation of lead concentration in the air
F. Personal protection
Masks: they must be regularly cleaned and filters replaced.
A-Pre-employment medical examination
Subjects suffering from anemia, kidney diseases; pregnant or breast-feeding women, should be kept away from lead exposure. According to Cramer (1966), alcoholism would make workers more sensitive to the toxic action of lead.
B-Periodical examination
It is necessary to seek and recognize the signs of lead impregnation and the first symptoms and clinical signs of lead poisoning, and to prescribe the biological tests cited above such as BLL and ZPP.
In the case of chronic intoxication, tests for kidney function can also be indicated.
In the USA, the Action Level (AL) is .03 mg/m3 of air. The general industry standard requires that all employees exposed to or above the AL for more than 30 days per year take part in a medical surveillance program provided by the employer, regardless of whether respiratory protection is used. Routine measurements of BLL and ZPP supplement the information provided by air lead measurements to guide prevention efforts.
C-Medical Evaluations
1. General industry standard :
a- A medical examination must be undergone by all the candidates for employment where an exposure to lead higher than the AL during more than 30 days per year is encountered. This examination must comprise a clinical evaluation and laboratory tests.
b- When the last BLL was = or > 1.93 µmol/L. but lower than the threshold recommended to carry out Medical Removal Protection.
c- When a single BLL is = or > 2.896 µmol/L. or when the average of the last three (3) BLLs, or of all the BLLs of the previous six (6) months are = or > than 2.413 µmol/L. (whichever covers a longer time period), Medical Removal Protection becomes mandatory.
d- When an employee reports signs or symptoms of lead toxiciy, desires advice about effects of lead exposure (on reproductive system, child bearing, etc.), has increased risk of material impairment to health due to lead exposure, or has difficulty breathing with respirator use.
2. Construction Industry Standard :
It will not be discussed here because it is irrelevant.
D- Medical Removal Protection
The physician must recommend to the employer that an employee be removed from lead exposure and enter a Medical Removal Protection program if any of the following conditions are met.
1. General Industry Standard :
a-A single BLL=or> 2.896 µmol/L, or
b-An average of the last three (3) BLLs or of all BBLs over the previous 6 months (whichever covers a longer period of time) is=or>2.413 µmol/L.
c-The employee has a « detected medical condition » that places him or her at increased risk of « material impairment to health ». The physician is given the discretion to make such a determination on an individual case basis.
d-When the physician detects symptoms and/or clinical signs usually associated with lead poisoning even if the BLL is lower than the standards cited above, or when the employee is pregnant.
e-When the employee is withdrawn from work, Laboratory Testing (Biological Monitoring) must be done at least once per month.
f-When the BLL is twice consecutively = or < 1.93 µmol/L. the physician may recommend the return to work provided that the employer has taken proper steps to control lead exposure and that the symptoms/ clinical signs of the intoxication have disappeared.
g-During Medical Removal Protection a physician may recommend that an employee, if physically able, returns to work in a place where there is no lead exposure, or in a place where lead exposure is below the AL (Action Level) which is below .03 mg/m3.
2. Construction Industry Standard
It will not be discussed here because it is irrelevant.
It consists of :
a gastric lavage with a solution precipitating lead in the form of insoluble sulphate, for example :
A-Chelation Therapy :
Finally, let us remember that the preventive administration of a chelating agent is to be prohibited. Only the control of the work environment represents the method of adequate prevention. A drug cannot replace industrial hygiene measures.
B-Symptomatic Treatment :
It is of various types
In the case of renal impairment, peritoneal dialysis allows a significant and fast elimination of lead, avoiding kidney poisonous chelating drugs.
In the case of lead impregnation, hazard control is a must (prevention measures, job change) and possibly, an EDTA treatment in the adult, 4g/day by mouth, during 5 to 10 days. By mouth, dimercaptosuccinic acid (DMSA) seems more active than EDTA.
By Edouard Bastarache

This picture has its own page with more detail, click here to see it.
This piece was bought in Sinaloa in 2020 (made in Puebla). By breaking it and refiring shards, I estimate the firing temperature at around 1800F. This lead test procedure involves leaving white vinegar in the piece overnight, pouring some of that into a test tube, dipping a cotton swab into a reagent solution and then stirring the vinegar with it. Darkening of the color indicates the concentration of lead in the leachate. It has turned black! Yet a typical fritted lead bisilicate PbO:2SiO2 glaze (having 10-15% clay to suspend it) does not leach lead (when melted well). The very thin glaze application suggests potters were trying to save money (although thin or thick does not make it more reachable). Frits are expensive, so it seems likely they are using white lead powder. But they are not mixing enough silica to produce a stable lead silicate chemistry (likely because adding silica would require firing at a higher temperature to get a good melt).
Yet this pottery is a tradition in Mexican culture (and elsewhere) and is used for food and liquid surfaces everywhere. Some manufacturers are trying to make stoneware that retains the traditional terra cotta appearance, but many prefer this.
| Typecodes |
Article by Edouard Bastarache
Edouard Bastarache is a well known doctor that has written many articles on the subject of toxicity of ceramic materials and books on technical aspects of ceramics. He writes in both English and French. |
| Materials |
Red Lead
A potent low-fire flux and metal oxide color enhancer. |
| Materials |
Litharge
|
| Materials |
Lead Carbonate
|
| Materials |
Lead Bisilicate Frit
A standard frit of 1 molar part of PbO and 2 of SiO2. It is considered stable and non-leachable. |
| Materials |
Lead Monosilicate Frit
A standard frit of 1 molar part of PbO and 1 of SiO2. It melts lower than a lead bisilicate. |
| Hazards |
Lead in Ceramic Glazes
Lead glazes may or may not be hazardous. This topic is not as clear as you might think. |
| Glossary |
Lead in Ceramic Glazes
Lead is a melter in ceramic glazes and performs exceptionally well and must be misused to be toxic. It is also now environmentally pervasive. It is toxic and cumulative at any level of exposure. |
![]() PayPal | No tracking, No ads, No paywall, No transient content! Just organized, concise information constantly updated and improved. Was this helpful? Consider supporting me. |
Buy me a coffee and we can talk